SPRB
Spruce Biosciences, Inc.
48.60$
+2.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 0.6% | 0.6% | 0.7% | 502.5% | – | – | – | – | – | – | – | – | – | |
| 100.0% | 99.4% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | |
| 439.1% | 384.5% | 515.3% | 502.5% | 1,088.7% | 3,078.5% | 1,554.8% | – | – | – | – | – | – | |
| 105.3% | 102.2% | 215.7% | 220.9% | 574.1% | 475.5% | 524.4% | – | – | – | – | – | – | |
| 544.5% | 486.1% | 731.0% | 723.4% | 1,662.8% | 3,553.9% | 2,079.2% | – | – | – | – | – | – | |
| -444.5% | -386.7% | -631.0% | -623.4% | -1,562.8% | -3,453.9% | -2,079.2% | – | – | – | – | – | – | |
| 3.9% | 3.7% | 4.8% | 5.2% | 11.8% | 8.0% | 5.2% | – | – | – | – | – | – | |
| -402.0% | -344.6% | -580.7% | -570.2% | -1,440.4% | -3,380.1% | -2,014.5% | – | – | – | – | – | – | |
| -0.6% | -33.4% | -1.4% | – | – | – | – | – | – | – | – | – | – | |
| -402.0% | -344.6% | -580.7% | -570.2% | -1,440.4% | -3,380.1% | -2,014.5% | – | – | – | – | – | – | |
| -397.6% | -340.4% | -575.1% | -564.3% | -1,426.9% | – | -2,008.5% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.